AAAAAA
Results:
1-16
|
Results: 16
Authors:
Stewart, ZA
Pietenpol, JA
Citation: Za. Stewart et Ja. Pietenpol, Syk: a new player in the field of breast cancer, BREAST CA R, 3(1), 2001, pp. 5-7
Authors:
Stewart, ZA
Tang, LJ
Pietenpol, JA
Citation: Za. Stewart et al., Increased p53 phosphorylation after microtubule disruption is mediated in a microtubule inhibitor- and cell-specific manner, ONCOGENE, 20(1), 2001, pp. 113-124
Authors:
Ji, C
Amarnath, V
Pietenpol, JA
Marnett, LJ
Citation: C. Ji et al., 4-hydroxynonenal induces apoptosis via caspase-3 activation and cytochromec release, CHEM RES T, 14(8), 2001, pp. 1090-1096
Authors:
Stewart, ZA
Pietenpol, JA
Citation: Za. Stewart et Ja. Pietenpol, p53 signaling and cell cycle checkpoints, CHEM RES T, 14(3), 2001, pp. 243-263
Authors:
Szak, ST
Mays, D
Pietenpol, JA
Citation: St. Szak et al., Kinetics of p53 binding to promoter sites in vivo, MOL CELL B, 21(10), 2001, pp. 3375-3386
Authors:
Tahir, SK
Han, EKH
Credo, B
Jae, HS
Pietenpol, JA
Scatena, CD
Wu-Wong, JSR
Frost, D
Sham, H
Rosenberg, SH
Ng, SC
Citation: Sk. Tahir et al., A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors, CANCER RES, 61(14), 2001, pp. 5480-5485
Authors:
Song, SY
Meszoely, IM
Coffey, RJ
Pietenpol, JA
Leach, SD
Citation: Sy. Song et al., K-Ras-independent effects of the farnesyl transferase inhibitor L-744,832 on cyclin B1/Cdc2 kinase activity, G2/M cell cycle progression and apoptosis in human pancreatic ductal adenocarcinoma cells, NEOPLASIA, 2(3), 2000, pp. 261-272
Authors:
Flatt, PM
Pietenpol, JA
Citation: Pm. Flatt et Ja. Pietenpol, Mechanisms of cell-cycle checkpoints: At the crossroads of carcinogenesis and drug discovery, DRUG METAB, 32(3-4), 2000, pp. 283-305
Authors:
Flatt, PM
Polyak, K
Tang, LJ
Scatena, CD
Westfall, MD
Rubinstein, LA
Yu, J
Kinzler, KW
Vogelstein, B
Hill, DE
Pietenpol, JA
Citation: Pm. Flatt et al., p53-dependent expression of PIG3 during proliferation, genotoxic stress, and reversible growth arrest, CANCER LETT, 156(1), 2000, pp. 63-72
Authors:
Flatt, PM
Tang, LJ
Scatena, CD
Szak, ST
Pietenpol, JA
Citation: Pm. Flatt et al., p53 Regulation of G(2) checkpoint is retinoblastoma protein dependent, MOL CELL B, 20(12), 2000, pp. 4210-4223
Authors:
Stewart, ZA
Pietenpol, JA
Citation: Za. Stewart et Ja. Pietenpol, Cell cycle checkpoints as therapeutic targets, J MAMMARY G, 4(4), 1999, pp. 389-400
Authors:
Norgaard, P
Law, B
Joseph, H
Page, DL
Shyr, Y
Mays, D
Pietenpol, JA
Kohl, NE
Oliff, A
Coffey, RJ
Poulsen, HS
Moses, HL
Citation: P. Norgaard et al., Treatment with farnesyl-protein transferase inhibitor induces regression of mammary tumors in transforming growth factor (TGF) alpha and TGF alpha/neu transgenic mice by inhibition of mitogenic activity and induction of apoptosis, CLIN CANC R, 5(1), 1999, pp. 35-42
Authors:
Stewart, ZA
Leach, SD
Pietenpol, JA
Citation: Za. Stewart et al., p21(Waf1/Cip1) inhibition of cyclin E Cdk2 activity prevents endoreduplication after mitotic spindle disruption, MOL CELL B, 19(1), 1999, pp. 205-215
Authors:
Szak, ST
Pietenpol, JA
Citation: St. Szak et Ja. Pietenpol, High affinity insertion/deletion lesion binding by p53 - Evidence for a role of the p53 central domain, J BIOL CHEM, 274(6), 1999, pp. 3904-3909
Authors:
Peek, RM
Blaser, MJ
Mays, DJ
Forsyth, MH
Cover, TL
Song, SY
Krishna, U
Pietenpol, JA
Citation: Rm. Peek et al., Helicobacter pylori strain-specific genotypes and modulation of the gastric epithelial cell cycle, CANCER RES, 59(24), 1999, pp. 6124-6131
Authors:
Stewart, ZA
Mays, D
Pietenpol, JA
Citation: Za. Stewart et al., Defective G(1)-S cell cycle checkpoint function sensitizes cells to microtubule inhibitor-induced apoptosis, CANCER RES, 59(15), 1999, pp. 3831-3837
Risultati:
1-16
|